Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (71-80 of 319) with videos related to

Pageof 32
Sort By:
The Journal of Experimental Medicine|June 27, 2007
Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleenMichele L Caton, Matthew R Smith-Raska, Boris Reizis
JAMA|March 9, 2016
Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJustin C Voog, Matthew R Smith, Jason A Efstathiou
Headache|April 28, 2023
Common challenges in the development of prediction modelsTimothy T Houle, Matthew R Smith, Dana P Turner
Journal of General Internal Medicine|October 20, 2009
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapyPhilip J Saylor, Nancy L Keating, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancerPhilip J Saylor, Richard J Lee, Matthew R Smith
BJU International|May 6, 2008
Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?Matthew R Smith, A James O'Malley, Nancy L Keating
Cancer|August 24, 2005
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinomaHang Lee, Katelyn McGovern, Joel S Finkelstein, et al.
Clinical Medicine Insights. Oncology|August 31, 2012
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumabAllan Lipton, Matthew R Smith, Georgiana K Ellis, et al.
Cancer|April 28, 2011
Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancerMatthew R Smith, Richard Cook, Ker-Ai Lee, et al.
Lancet (London, England)|July 20, 2015
Effects of decreases of animal pollinators on human nutrition and global health: a modelling analysisMatthew R Smith, Gitanjali M Singh, Dariush Mozaffarian, et al.
Pageof 32

Showing results (71-80 of 319) with videos related to

Sort By:
Pageof 32
The Journal of Experimental Medicine|June 27, 2007
Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleenMichele L Caton, Matthew R Smith-Raska, Boris Reizis
JAMA|March 9, 2016
Radiation With or Without Androgen Deprivation Therapy for Localized Prostate CancerJustin C Voog, Matthew R Smith, Jason A Efstathiou
Headache|April 28, 2023
Common challenges in the development of prediction modelsTimothy T Houle, Matthew R Smith, Dana P Turner
Journal of General Internal Medicine|October 20, 2009
Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapyPhilip J Saylor, Nancy L Keating, Matthew R Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancerPhilip J Saylor, Richard J Lee, Matthew R Smith
BJU International|May 6, 2008
Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?Matthew R Smith, A James O'Malley, Nancy L Keating
Cancer|August 24, 2005
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinomaHang Lee, Katelyn McGovern, Joel S Finkelstein, et al.
Clinical Medicine Insights. Oncology|August 31, 2012
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumabAllan Lipton, Matthew R Smith, Georgiana K Ellis, et al.
Cancer|April 28, 2011
Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancerMatthew R Smith, Richard Cook, Ker-Ai Lee, et al.
Lancet (London, England)|July 20, 2015
Effects of decreases of animal pollinators on human nutrition and global health: a modelling analysisMatthew R Smith, Gitanjali M Singh, Dariush Mozaffarian, et al.
Pageof 32